Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of Genomic Signatures for Colorectal Cancer Survival Using Exploratory Data Mining.

International journal of molecular sciences - 12 Mar 2024

Hummel Justin J, Liu Danlu, Tallon Erin, Snyder John, Warren Wesley, Shyu Chi-Ren, Mitchem Jonathan, Cortese Rene

Abstract excerpt

Clinicopathological presentations are critical for establishing a postoperative treatment regimen in Colorectal Cancer (CRC), although the prognostic value is low in Stage 2 CRC. We implemented a novel exploratory algorithm based on artificial intelligence (explainable artificial intelligence, XAI) that integrates mutational and clinical features to identify genomic signatures by repurposing the FoundationOne...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Artificial Intelligence
Share to Colorectal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Genomics

Share to Mutation

Share to Neoplasm Recurrence, Local

Source

Open in PubMed Open full text

Identifiers

PMID: 38542194
DOI: 10.3390/ijms25063220
PMCID: PMC10970183

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of Genomic Signatures for Colorectal Cancer Survival Using Exploratory Data Mining.PMID 38542194Read ↗

A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancer.Semantic proximity Read ↗

Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer.Semantic proximity Read ↗

A network-based gene expression signature informs prognosis and treatment for colorectal cancer patients.Semantic proximity Read ↗

Novel Artificial Intelligence Combining Convolutional Neural Network and Support Vector Machine to Predict Colorectal Cancer Prognosis and Mutational Signatures From Hematoxylin and Eosin Images.Semantic proximity Read ↗

Artificial Intelligence-Driven Precision Oncology Uncovers Prognostic Significance of RTK-RAS Alterations in FOLFOX-Treated Early-Onset Colorectal CancerSemantic proximity Read ↗

Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.Semantic proximity Read ↗

Artificial Intelligence Reveals Prognostic TP53 Pathway Alterations in FOLFOX-Treated Early-Onset Colorectal Cancer Among Populations at RiskSemantic proximity Read ↗

Step-by-step Elimination Algorithm Based on Modified Radial Data Visualization to Predict the Response to FOLFOX Treatment of CRC PatientsSemantic proximity Read ↗

Feature Importance in Predicting Clinical Outcome: Statistics vs. Explainable Artificial IntelligenceSemantic proximity Read ↗

Artificial Intelligence to Decode Cancer Mechanism: Beyond Patient Stratification for Precision OncologySemantic proximity Read ↗

Discovering Novel Prognostic Biomarkers of Hepatocellular Carcinoma using eXplainable Artificial IntelligenceSemantic proximity Read ↗

Artificial Intelligence-Enabled Integration Suggests TP53 Pathway Alterations as Prognostic Biomarkers in Populations with Disproportionate Health Burdens.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.